Analysis-Nike’s struggles test investor confidence in CEO Hill’s turnaround effort

Nike shares fell about 9%-10% in premarket trading to roughly $31.58, a 12-year low, after a revenue miss and guidance for steeper-than-expected sales and profit declines through the fiscal year ending May 2028. The company announced further job cuts, but said most restructuring savings will not materialize until fiscal 2029-30. Persistent weakness in China, sportswear and the Jordan brand—together more than half of sales—signals that CEO Elliott Hill's turnaround will take longer than investors expected.

Analysis

The key underwriting change is not another weak quarter but a multi-year mismatch between revenue repair and cost realization. NKE is likely to face negative operating leverage through FY28 as wholesale re-entry requires retailer margin support and inventory availability, while direct-channel deleveraging and China investments absorb savings. A lower-margin wholesale mix can stabilize volume, but it is unlikely to restore prior EBIT margins without demonstrable full-price sell-through; the November investor day must therefore provide segment-level gross-margin and inventory targets, not another brand narrative.

Competitive beneficiaries are ONON, DECK and HOKA owner DECK, plus ASICSY: each has captured performance-running shelf space and consumer attention while NKE resets product calendars. Foot Locker (FL) and Dick's (DKS) gain negotiating leverage and potentially improved traffic from a better-supplied Nike assortment, but their near-term exposure remains mixed if NKE's promotional activity intensifies. The larger second-order risk is category-wide pricing: clearing excess lifestyle inventory can force markdown responses from adidas (ADDYY), PUMA (PMMAF) and retailers, limiting gross-margin upside across athletic footwear into the next few seasons.

Consensus may treat the selloff as a valuation-floor opportunity, but a low absolute share price does not protect against further multiple compression if FY28 becomes the first credible earnings reset rather than the trough. The contrarian bullish case is that management is deliberately front-loading impairments, promotional cleanup and restructuring pain ahead of investor day; a concrete plan to reduce Jordan supply, improve China sell-through and quantify savings could trigger a sharp 1-3 month relief rally. That thesis is falsified by another guidance cut, worsening wholesale orders, or evidence that full-price selling fails to improve despite lower Jordan launch volumes.

Key Decisions for Investors

• Avoid initiating a core NKE long before the November 16-17 investor day; use the event as a decision point. Require explicit FY28 revenue, gross-margin, inventory and restructuring-cash-cost targets before underwriting a turnaround.
• For a tactical event trade, buy a defined-risk NKE call spread expiring December 2026 only if implied volatility remains below the expected post-event move; target a 15-25% relief rally on credible targets, with premium at risk rather than unhedged equity exposure.
• Maintain a 6-12 month relative long DECK / short NKE pair, sized beta-neutral. DECK's performance-running momentum and HOKA shelf productivity should remain advantaged while NKE repairs product and channel execution; exit if NKE reports sustained full-price sell-through and wholesale order acceleration.
• Watch FL and DKS quarterly footwear gross margin and Nike inventory commentary as leading indicators. Improving retailer turns without heavier promotions would validate a cleaner NKE reset; broad markdown pressure would support a cautious stance on the entire athletic-footwear complex.